Skip to main content
SpringerLink
Log in

Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Normocalcemic (incipient) primary hyperparathyroidism (PHPT) is characterized by inappropriately elevated parathyroid hormone (PTH) levels in the setting of normal serum calcium. The biochemical and skeletal outcomes after parathyroidectomy for normocalcemic PHPT are not well-described.

Methods

All patients who underwent parathyroidectomy for normocalcemic PHPT at a single institution were retrospectively reviewed (2006–2016). Pre- and postoperative calcium, PTH, and bone mineral density (BMD) were compared between patients with normalized versus persistently elevated PTH levels > 6 months after parathyroidectomy. Multivariable Cox regression was used to identify risk factors associated with persistently elevated PTH levels after parathyroidectomy.

Result

Parathyroidectomy was performed in 71 patients with normocalcemic PHPT, of whom 38 (53.5%) had multi-gland disease. No patients became hypercalcemic, with a median follow-up of 23.1 months. Persistently elevated PTH levels were noted in 33 (46.5%) patients. In multivariable analysis, preoperative PTH > 100 pg/mL was associated with persistently elevated PTH levels after parathyroidectomy. In 38 patients with available pre- and postoperative BMD measurements, the mean preoperative BMD improved + 5.6% (p < 0.01) in patients with normalized PTH, while no significant change was observed in patients with persistently elevated PTH levels (− 2.2%, p = 0.47).

Conclusions

Elevated PTH levels are common after parathyroidectomy for normocalcemic PHPT. Improvements in BMD may be predicated on long-term normalized PTH levels following surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92(8):3001–5.

    Article  CAS  PubMed  Google Scholar 

  3. Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):366–72.

    Article  CAS  PubMed  Google Scholar 

  4. Wade TJ, Yen TW, Amin AL, Wang TS. Surgical management of normocalcemic primary hyperparathyroidism. World J Surg. 2012;36(4):761–6.

    Article  PubMed  Google Scholar 

  5. Koumakis E, Souberbielle JC, Sarfati E, et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab. 2013;98(8):3213–20.

    Article  CAS  PubMed  Google Scholar 

  6. Yeh MW, Zhou H, Adams AL, et al. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study. Ann Intern Med. 2016;164(11):715–23.

    Article  PubMed  Google Scholar 

  7. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Calvi LM, Bushinsky DA. When is it appropriate to order an ionized calcium? Journal of the American Society of Nephrology. 2008;19(7):1257–60.

    Article  CAS  PubMed  Google Scholar 

  9. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665–70; discussion 670–2.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246(6):976–80; discussion 980–1.

    Article  PubMed  Google Scholar 

  11. Ning L, Sippel R, Schaefer S, Chen H. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism? Ann Surg. 2009;249(3):469–72.

    Article  PubMed  Google Scholar 

  12. Carsello CB, Yen TW, Wang TS. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter? Surgery. 2012;152(4):575–81; discussion 581–3.

    Article  PubMed  Google Scholar 

  13. Goldfarb M, Gondek S, Irvin GL, Lew JI. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery. 2011;150(6):1076–84.

    Article  PubMed  Google Scholar 

  14. Yen TW, Wilson SD, Krzywda EA, Sugg SL. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery. 2006;140(4):665–72; discussion 672–4.

    Article  PubMed  Google Scholar 

  15. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959–68.

    Article  PubMed  Google Scholar 

  16. Lee DTW, Chabot JA, Lee JA, Kuo JH. Bone Mineral Density Changes After Curative Parathyroidectomy: An Analysis of Patients with Primary Hyperparathyroidism According to Biochemical Profiles. American Association of Endocrine Surgeons Annual Meeting; 6 May 2018; Durham, NC.

  17. Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003;88(10):4641–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

    Shonan Sho MD, Eric J. Kuo MD, Angela C. Chen BS, Michael W. Yeh MD & Masha J. Livhits MD

  2. Department of Biomathematics, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

    Ning Li PhD

Authors
  1. Shonan Sho MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric J. Kuo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela C. Chen BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ning Li PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael W. Yeh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masha J. Livhits MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masha J. Livhits MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sho, S., Kuo, E.J., Chen, A.C. et al. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26, 539–546 (2019). https://doi.org/10.1245/s10434-018-6998-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6998-0

Keywords

Search

Navigation